Does Rallies show SER price targets?

Yes. Rallies tracks SER analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.

Is SER research on Rallies investment advice?

No. Rallies provides research, data, and educational context for SER. It does not provide personalized investment advice.

SER (Serina Therapeutics, Inc.) Stock Analysis - Analyst Ratings

Serina Therapeutics, Inc. (SER) is a publicly traded Healthcare sector company. As of November 12, 2026, SER trades at $1.43 with a market cap of $38.10M and a P/E ratio of -1.04. SER moved -6.00% today. Year to date, SER is -31.54%; over the trailing twelve months it is -64.58%. Its 52-week range spans $1.14 to $7.92. Analyst consensus is buy with an average price target of $9.50. Rallies surfaces SER's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate SER?

2 analysts cover SER: 0 strong buy, 2 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $9.50.

SER Key Metrics

Key financial metrics for SER
Metric	Value
Price	$1.43
Market Cap	$38.10M
P/E Ratio	-1.04

EPS	$-1.91

Dividend Yield	0.00%

52-Week High	$7.92

52-Week Low	$1.14

Volume	28.22K

Avg Volume	0

Revenue (TTM)	$130.00K

Net Income	$-19.21M

Gross Margin	0.00%

Common questions about SER

What do analysts rate SER?: 2 analysts cover SER: 0 strong buy, 2 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $9.50.
Does Rallies show SER price targets?: Yes. Rallies tracks SER analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is SER research on Rallies investment advice?: No. Rallies provides research, data, and educational context for SER. It does not provide personalized investment advice.

Serina Therapeutics

Analysts

Serina Therapeutics

Analysts

SER Analyst Consensus

Common questions about SER